14-day Premium Trial Subscription Try For FreeTry Free
NASDAQ:RXII
Delisted

RXI Pharmaceuticals Corporation Fund Signals

$0.82
+0 (+0%)
At Close: Dec 08, 2023

Latest Data & Signals Issued

Signal Type Signal Value Data
Score 0.000 445 days ( 0 % )
Last Price $0.82 0 %
High/ Low $0.82 - $0.82 0%
Chg 7 Days N/A $0.82 $0.82
Chg 30 Days N/A $0.82 $0.82
Chg 12 mos N/A $0.82 $0.82
Trend - 3 mos N/A Width: 0.00000000 %
Trend - 12 mos N/A Width: 0.00000000 %
Pred. range - 3 mos $0.82 - $0.82 0 % - 0 %
Pred. range - 12 mos $0.82 - $0.82 0 % - 0 %
Short MA avg 3 mos Sell Nov 30, -1 - N/A days
Long MA avg 3 mos Sell Nov 30, -1 - N/A days
Short/Long MA avg 3 mos Sell Nov 30, -1 - N/A days
Short MA avg 12 mos Sell Nov 30, -1 - N/A days
Long MA avg 12 mos Sell Nov 30, -1 - N/A days
Short/Long MA avg 12 mos Sell Nov 30, -1 - N/A days
Pivot Short Buy Dec 07, 2023 - 2 days
Bollinger Sell Nov 30, -1 - N/A days
MACD N/A No Dates Stored For This Signal
Click to get the best stock tips daily for free!

About RXI Pharmaceuticals Corporation

RXi Pharmaceuticals Corporation, a clinical-stage RNAi company, focuses on discovering and developing therapies primarily in the areas of dermatology and ophthalmology. The company develops therapies based on siRNA technology and immunotherapy agents. Its clinical development programs include RXI-109, a self-delivering RNAi compound, which is in Phase IIa clinical trial that is used to prevent or reduce dermal scarring following surgery or trauma... RXII Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT